NASDAQ:QLGN
Delisted

Qualigen Therapeutics Stock Predictions

etoro logo Buy QLGN
*Your capital is at risk
$3.21
+0 (+0%)
At Close: Feb 17, 2026
Currently predicting for Fri, 5 Jun 2026

QLGN Prediction Chart

QLGN Predictions History

Latest community submissions for QLGN.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 8, 2024 Bullish $0.280 X 0
JS JS Pro
May 17, 2021 $1.66 -99.82% $1.80 X 92.22% 1
May 17, 2021 Bearish $1.80 V 0
You Decide Say What You Decide Say What @YouDecideSayWhat.207513
Mar 9, 2021 Bearish $3.26 V 0
Mar 9, 2021 $9.01 -99.45% $3.26 X 0.00% 1
Nov 11, 2020 Bullish $3.59 X 1
JS JS Pro
Nov 11, 2020 $3.31 -99.82% $3.59 V 92.20% 0
Ado Bulj Ado Bulj @AdoBulj.168611
Nov 11, 2020 Bullish $3.59 X 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 23, 2020 $4.63 -99.81% $4.93 V 93.91% 1
JS JS Pro
Sep 23, 2020 $4.98 -99.80% $4.93 V 98.99% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for QLGN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT QUALIGEN THERAPEUTICS INC.
Qualigen Therapeutics
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that block...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE